EE541 Health Equity Improvements Driven By Faricimab for the Treatment of Diabetic Macular Edema in an Aggregate Distributional Cost-Effectiveness Analysis from an English NHS Perspective
Abstract
Authors
A. Meunier O. Opeifa O. Cox C. Bührer S.P. Kelly R. Gale